princeton nj oct 25 2021 globe newswire certara inc nasdaq cert a global leader in biosimulation today announced that its simcyp covid19 vaccine model has won an rd 100 award which recognizes the top 100 rd pioneers and their revolutionary ideas in science and technology in the past year the model which is incorporated in certaras vaccine simulator has been used by major pharmaceutical companies and allows researchers to study how a vaccine is handled by the human body in computergenerated virtual populations we are proud and honored that the rd 100 awards judges recognized the important contributions being made by certaras biosimulation software during this pandemic said piet van der graaf pharmd phd senior vice president of quantitative systems pharmacology at certara our covid19 vaccine model is being used to determine optimal vaccine doses and timing between doses investigate differences in immune response with age and ethnicity evaluate the duration of immune response after vaccination and identify the best booster sequencing for covid19 vaccines we are also now applying our vaccine simulator to develop vaccines for oncology and respiratory syncytial virus certaras simcyp covid19 vaccine model has demonstrated that it can accurately predict the outcomes of actual clinical trials using covid19 vaccines its prediction that the optimal timing between the first two covid19 vaccine doses is eight weeks was validated by the pitch study conducted at oxford university certara calibrated its model using covid19 vaccine structures and validated it by replicating the published clinical data furthermore results from the model have been presented by companies developing covid19 vaccines at the american college of clinical pharmacy accp and american association of pharmaceutical scientists aaps as well as to global regulatory agencies including the us fda established in 1963 the rd 100 awards program is an annual worldwide competition held by rd world magazine that identifies new commercial products technologies and materials for their technological significance covering diverse industry sectors this years competition received entries from 17 countriesregions and they were evaluated by a judging panel that included nearly 40 wellrespected industry professionals across the globe about certara certara accelerates medicines using proprietary biosimulation software and technology to transform traditional drug discovery and development its clients include more than 1650 global biopharmaceutical companies leading academic institutions and key regulatory agencies across 61 countries certara contact jieun choe chief strategy and marketing officer jieunchoecertaracom media contacts lisa osborne rana healthcare solutions lisaranahealthcom ariane lovell finn partners arianelovellfinnpartnerscom investor relations contact david deuchler gilmartin group ircertaracom